Data Availability StatementThe content data used to aid the findings of the study can be found through the corresponding writer upon demand. its features through the signaling pathways of ERK1/2 aswell as Wnt/(TGF-and ERK1/2 got some human relationships with DHA’s convenience of inducing MSC osteogenic differentiation. The pathway of ERK can be mixed up in protein kinase pathway which is activated by mitogen. The adipose-derived stem cells’ osteogenic reaction would be decreased by ERK1/2 signaling pathway inhibition . Nevertheless, Lund et al.  pointed that the prohibition of the SNS-032 signaling pathway of ERK1/2 augmented the osteogenic reaction in hMSCs, which may be dependent on the cell type or treatment used. In our research, DHA could promote expression of RUNX2 and the ERK. RUNX2 is a key transcription factor for osteogenesis. However, when using U0126 to inhibit the ERK1/2 signaling pathway, we found that the matrix mineralization and protein expression of RUNX2 were adequately decreased, demonstrating that the pathway of ERK1/2 significantly affects DHA-induced osteogenic differentiation. Another significant pathway that is included in osteogenesis is the Wnt/and SNS-032 ERK signaling pathways existing. Third, we did not SNS-032 conduct an in vivo experiment to prove that DHA promoted fracture healing. In conclusion, our study indicates that DHA has no significant effect on the proliferation of hMSCs but SNS-032 enhances osteogenic differentiation via the signaling pathways of Wnt/as well as ERK1/2 (Figure 6). Open in a separate window Figure 6 Schematic diagram of the signaling pathways involved in osteoblast differentiation induced by DHA. DHA promotes osteoblast differentiation through the ERK and Wnt/ em /em -catenin signaling pathways. Acknowledgments The research was sustained by the Zhejiang Medical and Health Science and Technology Plan Project (Nos. 2015KYB182, 2016ZDA008, 2017KY382, and 2019KY080), the National Natural Science Foundation of China (Nos. FBL1 81871759 and 81672147), and the Zhejiang Provincial Natural Science Foundation of China (Nos. LY18H060003, LY16H060003, and LQ18H050005). Data Availability The article data used to support the findings of this study are available from the corresponding author upon request. Conflicts appealing any issues are reported by Zero writer of curiosity..